Retrieve Medical Holdings, Inc.
RMHIdata completeness 50%15 fiscal years on fileData notes: no data for concept 'revenue'
i. The business — what you’d actually own
| Figure | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net income | −$28,4071 | −$13,9932 | −$15,0113 | −$76,0894 | −$164,9695 |
| Operating cash flow | −$43,7216 | −$1,7437 | −$1198 | −$14,2569 | −$68,55310 |
| Capital expenditure | — | — | — | — | — |
| Free cash flow (derived) | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $011 | $012 | $013 | — | — |
| Diluted shares | 78.4M | 78.4M | 78.4M | 78.4M | 78.4M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.06
your share of equity
Profit it earned you last year
−$0.02
Free cash flow it threw off
—
Debt you’d be carrying
—
10 shares is a claim on −$0.06 of net worth that earned you −$0.02 last year.
iii. Is this a good business?
Moat signal · return on equity
— avg · 5y
Not enough data in the filings for a return-on-capital reading.
seeing a moat in the numbers →Management signal · capital allocation
−0% shares · 5y
Share count is roughly flat over 5 years — little dilution, little buyback.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined
Different models answer different questions — which to trust when →
Sources — the receipts
- 10-K · period ending 2018-09-30 · accession 0001199835-22-000806 (NetIncomeLoss)
- 10-K · period ending 2019-09-30 · accession 0001199835-22-000814 (NetIncomeLoss)
- 10-K · period ending 2020-09-30 · accession 0001199835-22-000822 (NetIncomeLoss)
- 10-K · period ending 2021-09-30 · accession 0001199835-22-000830 (NetIncomeLoss)
- 10-K · period ending 2022-09-30 · accession 0001199835-22-000838 (NetIncomeLoss)
- 10-K · period ending 2018-09-30 · accession 0001199835-22-000806 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2019-09-30 · accession 0001199835-22-000814 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2020-09-30 · accession 0001199835-22-000822 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-09-30 · accession 0001199835-22-000830 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-09-30 · accession 0001199835-22-000838 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2018-09-30 · accession 0001199835-22-000806 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2019-09-30 · accession 0001199835-22-000814 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2020-09-30 · accession 0001199835-22-000822 (CashAndCashEquivalentsAtCarryingValue)